Evidence map›Paper›PMID 23065715›Full record

ArticleMagnetic resonance in medicine2013

Divalent metal transporter, DMT1: a novel MRI reporter protein.

Benjamin B Bartelle, Kamila U Szulc, Giselle A Suero-Abreu, Joe J Rodriguez, Daniel H Turnbull

Open access · greenAbstract read
In one paragraph

Article in Magnetic resonance in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Reconfiguration of brain-wide neural activity after early life adversity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Reconfiguration of brain-wide neural activity after early life adversity.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. A Genetically Engineered Reporter System Designed forJournal of the American Chemical Society · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Biogenic Imaging Contrast Agents.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  17. Article
  18. A primer onFrontiers in medicine · 2023
    Review
  19. Advanced functional materials · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Benjamin B BartelleKimmel Center for Biology and Medicine at the Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York, USA; Molecular Biophysics Graduate Program, New York University School of Medicine, New York, New York, USA.
Kamila U Szulc
Giselle A Suero-Abreu
Joe J Rodriguez
Daniel H Turnbull
New York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Ultrasound and MR Imaging of Mouse Brain Development.R01NS038461 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TURNBULL, DANIEL H · 1999 to 2016
$6.5M
Molecular ultrasound and MRI of Vascular Development. - Renewal - 1R01HL078665 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TURNBULL, DANIEL H · 2004 to 2017
$5.2M
NCI NIH HHS P30 CA0016087NCI NIH HHS P30 CA016087NHLBI NIH HHS R01 HL078665NINDS NIH HHS R01 NS038461
6 · The paper itself

Abstract

Manganese (Mn)-enhanced MRI (MEMRI) has found a growing number of applications in anatomical and functional imaging in small animals, based on the cellular uptake of Mn ions in the brain, heart, and other organs. Previous studies have relied on endogenous mechanisms of paramagnetic Mn ion uptake and enhancement. To genetically control MEMRI signals, we reverse engineered a major component of the molecular machinery involved in Mn uptake, the divalent metal transporter, DMT1. DMT1 provides positive cellular enhancement in a manner that is highly sensitive and dynamic, allowing greater spatial and temporal resolution for MRI compared to previously proposed MRI reporters such as ferritin. We characterized the MEMRI signal enhancement properties of DMT1-expressing cells, both in vitro and in vivo in mouse models of cancer and brain development. Our results show that DMT1 provides an effective genetic MRI reporter for a wide range of biological and preclinical imaging applications.

Indexed as

AnimalsBrain ChemistryCation Transport ProteinsIn Vitro TechniquesMagnetic Resonance ImagingManganeseMiceSolute Carrier Family 11, Member 2Cation Transport ProteinsManganeseSolute Carrier Family 11, Member 2manganese (Mn)Mn‐enhanced MRI (MEMRI)molecular imagingreporter protein

Identifiers

PMID23065715
PMCPMC3587026
OpenAlexW1874831549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.